Charles River Laboratories International Earnings

Charles River Laboratories International’s revenue jumped 0.59% since last year same period to $1032.14Mn in the Q2 2025. On a quarterly growth basis, Charles River Laboratories International has generated 4.87% jump in its revenue since last 3-months.

Charles River Laboratories International’s net profit fell -41.85% since last year same period to $52.33Mn in the Q2 2025. On a quarterly growth basis, Charles River Laboratories International has generated 105.45% jump in its net profits since last 3-months.

Charles River Laboratories International’s net profit margin fell -42.19% since last year same period to 5.07% in the Q2 2025. On a quarterly growth basis, Charles River Laboratories International has generated 95.9% jump in its net profit margins since last 3-months.

Charles River Laboratories International’s earning per share (EPS) estimates for the current quarter stand at 2.36 - a -7.45% fall from last quarter’s estimates.

Charles River Laboratories International’s earning per share (EPS) estimates for the current year stand at 2.36.

Charles River Laboratories International’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Charles River Laboratories International has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.